What kind of vendors are large pharma companies looking for?

Big pharma are trying to minimize the number of players they are dealing with. 13 Big Pharma players have signed 22 strategic pacts with CROs in the last 2 years. Pfizer has signed a contract with Parexel and ICON for Clinical process development Parexel is an international clinical research organization ICON offers a range of services starting from preclinical research to Phase IV Sanofi with Convance. Convance is to provide discovery, toxicology, chemistry, Phase 14, central lab and market access services. BMS Biocon Drug Discovery Centre - Bristol-Myers Squibb and Biocon entered into an agreement to develop integrated drug discovery and development capabilities at Syngene. What space do small players in CRO space have to offer? What part of the drug discovery process if being outsourced? Why? Clinical Development still accounts for majority of the outsourced work. US$ 10.6 Bn of the US$ 14.3 Bn CRO market in 2008 On site/ offshore model?